BridgeMD
New treatment option for Stroke
Official title Combined Effects of Soft Robotic Hand and Electrical Stimulation on Hand Function in Stroke Survivors
ClinicalTrials.gov ID: NCT07282938
What this study is testing
- What it's testing
- Stroke is a clinically delineated syndrome, which is characterised by an acute, focal neurological deficit resulting from vascular injury (infarction or haemorrhage) within the central nervous system. Notably, around 80 percent of stroke survivors experience post-stroke deficits in upper extremity (UE) motor performance, impacting grip strength, dexterity, and functional independence, which greatly hinder the ability of stroke patients to carry out activities of daily living (ADL), and in turn affects their overall quality of life (QOL).One potential solution to these difficulties is the creation of rehabilitation robotic devices that incorporate hand technology and electrical stimulation.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 45 to 65
You may be able to join if
- Diagnosed with their first episode of stroke.
- Participants with 3-6 months post stroke.
- Participants with normal cognition on Montreal Cognitive Assessment (MOCA) ≥24.
- Participants with the ability to extend Metacarpophalangeal (MCP) and Proximal Interphalangeal (PIP) joint to 180 degree passively
- Modified Ashworth Scale \< 2.
You likely can't join if
- Presence of other neurological, neuromuscular, orthopedic diseases, or
- conditions that may interfere with task performance.
- Participants with sensory disturbances in the fingers
See the full eligibility criteria
- Diagnosed with their first episode of stroke.
- Participants with 3-6 months post stroke.
- Participants with normal cognition on Montreal Cognitive Assessment (MOCA) ≥24.
- Participants with the ability to extend Metacarpophalangeal (MCP) and Proximal Interphalangeal (PIP) joint to 180 degree passively
- Modified Ashworth Scale \< 2.
- Participants with the score of 10 to 16 on National Institute of Health Stroke Scale Score (NIHSS Score).
- Presence of other neurological, neuromuscular, orthopedic diseases, or
- conditions that may interfere with task performance.
- Participants with sensory disturbances in the fingers
The study team makes the final eligibility decision.
Where it's taking place
- Lahore, Punjab Province, Pakistan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 45 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Lahore, Punjab Province, Pakistan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.